Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Sebastian J C M M Neggers

1-50 of 66 results

View this query on the Wikidata Query Service
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study

scientific article published on 4 August 2010
Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin

scientific article published on 16 August 2012
X-linked acrogigantism syndrome: clinical profile and therapeutic responses

scientific article
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

scientific article published on 17 July 2015
Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly

scientific article published on 17 June 2014
Des-Acyl Ghrelin: A Metabolically Active Peptide

scientific article published on April 25, 2013
Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone

scientific article
The Metabolic Syndrome in Adult Survivors of Childhood Cancer, a Review

scientific article published on April 1, 2010
Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration W

scientific article
Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review

scientific article published on 28 July 2009
Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy

scientific article published on 22 May 2017
Medical therapy of acromegaly: efficacy and safety of somatostatin analogues

scientific article
Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

scientific article
Combination treatment with somatostatin analogues and pegvisomant in acromegaly

scientific article
Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

scientific article
Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors

scientific article published on December 14, 2012
Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the [...]

scientific article
Long-Term Nephrotoxicity in Adult Survivors of Childhood Cancer

scientific article published on February 14, 2013
Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemia

scientific article published on 9 January 2013
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects

scientific article
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

scientific article published on 20 September 2016
Should We Consider Des-Acyl Ghrelin as a Separate Hormone and If So, What Does It Do?

scientific article published on 07 April 2014
β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly.

scientific article published on 29 October 2013
Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study).

scientific article published on 15 November 2017
Obesity Is Underestimated Using Body Mass Index and Waist-Hip Ratio in Long-Term Adult Survivors of Childhood Cancer

scientific article published on August 14, 2012
Somatostatin analog and pegvisomant combination therapy for acromegaly

scientific article published on October 2009
Emotional Distress in 652 Dutch Very Long-term Survivors of Childhood Cancer, Using the Hospital Anxiety and Depression Scale (HADS)

scientific article published on October 1, 2013
Pituitary dysfunction after aneurysmal subarachnoid haemorrhage: course and clinical predictors—the HIPS study

scientific article published on November 6, 2014
In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas.

scientific article published on 13 March 2017
Treatment factors rather than genetic variation determine metabolic syndrome in childhood cancer survivors

scientific article published in October 2012
Combined treatment of somatostatin analogues with pegvisomant in acromegaly

scientific article published on December 10, 2015
Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients

scientific article published on September 1, 2011
Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumors

scientific article published on February 1, 2013
Bridging the gap: metabolic and endocrine care of patients during transition

scientific article
Efficacy and Safety of switching to Pasireotide in Acromegaly Patients controlled with Pegvisomant and Somatostatin Analogues: PAPE extension study

scientific article published on 12 October 2018
What is active acromegaly and which parameters do we have?

scientific article published on May 1, 2012
Gonadal function recovery in very long-term male survivors of childhood cancer

scientific article published on January 5, 2013
Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions

scientific article published on 13 March 2018
Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study

scientific article published on June 5, 2015
A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues.

scientific article
Diagnostic value of a ghrelin test for the diagnosis of GH deficiency after subarachnoid hemorrhage

scientific article published on September 14, 2013
Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3

scientific article published on August 4, 2015
Pegvisomant Treatment in Acromegaly

scientific article published on March 19, 2015
Very long-term sequelae of craniopharyngioma.

scientific article
The limited screening value of insulin‐like growth factor‐i as a marker for alterations in body composition in very long‐term adult survivors of childhood cancer

scientific article published on December 11, 2011
Modulation of Glucocorticoid Metabolism by the GH-IGF-I Axis

scientific article published on December 16, 2010
Risk factors for subsequent endocrine-related cancer in childhood cancer survivors

scientific article
Adrenal function in adult long-term survivors of nephroblastoma and neuroblastoma

scientific article published on April 16, 2012
Pasireotide responsiveness in acromegaly is mainly driven by somatostatin receptor subtype 2 expression

scientific article published on 01 March 2019
In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life

scientific article published on April 15, 2014

Paulina is supported by:

About Paulina

Help